Market Cap 40.58M
Revenue (ttm) 0.00
Net Income (ttm) -4.52M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 1.72
Volume 124,500
Avg Vol 314,942
Day's Range N/A - N/A
Shares Out 441.58M
Stochastic %K 38%
Beta -0.76
Analysts Strong Buy
Price Target $4.00

Company Profile

Oncotelic Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment of orphan oncology indications. It develops antisense and small molecule injectable drugs for the treatment of cancer. The company is also developing OXi4503 for the treatment of acute myeloid leukemia and myelodysplastic syndromes; OT-101, an antisense against TGF-ß2, which is in phase 3 clinical trials for pancreatic cancer and glioblastoma, as well as for the treatme...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 635 7000
Fax: 650 635 7001
Address:
29397 Agoura Road, Suite 107, Agoura Hills, United States
NetworkNewsWire
NetworkNewsWire Dec. 4 at 7:12 PM
InvestorNewsBreaks – $OTLC identifies Biomarker Signature Predicting Sensitivity to IV Sapu003 https://ibn.fm/v99va
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 4 at 6:57 PM
#BreakingNews: $OTLC Oncotelic - MOMO'S BREAKOUT BOARD https://investorshangout.com/post/view?id=6805271
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 4 at 4:45 PM
#BreakingNews: $OTLC Oncotelic and Sapu Nano Announce DeciparticleTM Led Biomarker Framework Identifying Tumors Most Likely to Respond to IV Sapu003, an Intravenous Everolimus Nanomedicine https://www.reddit.com/r/StockInvest/comments/1pe2p8b/otlc_oncotelic_and_sapu_nano_announce/ #Stockstobuy #stockstowatch #OTLC #STOCK
0 · Reply
ckruel
ckruel Dec. 4 at 3:38 PM
$OTLC the call for 2026 is to shift investing into health care, a sector that has been beaten down, as other sectors may suffer in a bearish 2026 market, finally we may see some positive movement in the bio sector.
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 4 at 3:19 PM
#BreakingNews: $OTLC Oncotelic and Sapu Nano Announce DeciparticleTM Led Biomarker Framework Identifying Tumors Most Likely to Respond to IV Sapu003, an Intravenous Everolimus Nanomedicine https://www.globenewswire.com/news-release/2025/12/04/3199970/0/en/Oncotelic-and-Sapu-Nano-Announce-DeciparticleTM-Led-Biomarker-Framework-Identifying-Tumors-Most-Likely-to-Respond-to-IV-Sapu003-an-Intravenous-Everolimus-Nanomedicine.html #Stockstobuy #stockstowatch #OTLC #STOCK @Charles https://youtube.com/shorts/y3yBcwNvK0s
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 4 at 3:15 PM
BB's Stock Haven : $OTLC Oncotelic and Sapu Nano Announces... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177024478 via @Investors_Hub
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 4 at 2:39 PM
$OTLC Oncotelic and Sapu Nano Announces New PK Data Demonstrating IV Sapu003 Reduces GI Accumulation of Everolimus up to 67-Fold Compared With Oral Dosing https://www.stocktitan.net/news/OTLC/oncotelic-and-sapu-nano-announces-new-pk-data-demonstrating-iv-jwskm6p5fvuc.html #Stockstobuy #stockstowatch #OTLC #STOCK @Charles
0 · Reply
ckruel
ckruel Dec. 3 at 11:46 PM
$OTLC not counting any home run in their pipeline
0 · Reply
ckruel
ckruel Dec. 3 at 11:43 PM
$OTLC $OTLC so at this point that make the co. Worth about $1.69 per share, plus any blue sky on a buyout…anyone?
1 · Reply
Techallure
Techallure Dec. 3 at 8:47 PM
$OTLC $IBIO can only warn so many times … how many times have I mentioned as times such as this ? to be given a small clue, so small we can call it a sub-20 nm clue … and so small but transistor level output can take place Be Prepared
1 · Reply
Latest News on OTLC
No data available.
NetworkNewsWire
NetworkNewsWire Dec. 4 at 7:12 PM
InvestorNewsBreaks – $OTLC identifies Biomarker Signature Predicting Sensitivity to IV Sapu003 https://ibn.fm/v99va
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 4 at 6:57 PM
#BreakingNews: $OTLC Oncotelic - MOMO'S BREAKOUT BOARD https://investorshangout.com/post/view?id=6805271
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 4 at 4:45 PM
#BreakingNews: $OTLC Oncotelic and Sapu Nano Announce DeciparticleTM Led Biomarker Framework Identifying Tumors Most Likely to Respond to IV Sapu003, an Intravenous Everolimus Nanomedicine https://www.reddit.com/r/StockInvest/comments/1pe2p8b/otlc_oncotelic_and_sapu_nano_announce/ #Stockstobuy #stockstowatch #OTLC #STOCK
0 · Reply
ckruel
ckruel Dec. 4 at 3:38 PM
$OTLC the call for 2026 is to shift investing into health care, a sector that has been beaten down, as other sectors may suffer in a bearish 2026 market, finally we may see some positive movement in the bio sector.
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 4 at 3:19 PM
#BreakingNews: $OTLC Oncotelic and Sapu Nano Announce DeciparticleTM Led Biomarker Framework Identifying Tumors Most Likely to Respond to IV Sapu003, an Intravenous Everolimus Nanomedicine https://www.globenewswire.com/news-release/2025/12/04/3199970/0/en/Oncotelic-and-Sapu-Nano-Announce-DeciparticleTM-Led-Biomarker-Framework-Identifying-Tumors-Most-Likely-to-Respond-to-IV-Sapu003-an-Intravenous-Everolimus-Nanomedicine.html #Stockstobuy #stockstowatch #OTLC #STOCK @Charles https://youtube.com/shorts/y3yBcwNvK0s
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 4 at 3:15 PM
BB's Stock Haven : $OTLC Oncotelic and Sapu Nano Announces... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177024478 via @Investors_Hub
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 4 at 2:39 PM
$OTLC Oncotelic and Sapu Nano Announces New PK Data Demonstrating IV Sapu003 Reduces GI Accumulation of Everolimus up to 67-Fold Compared With Oral Dosing https://www.stocktitan.net/news/OTLC/oncotelic-and-sapu-nano-announces-new-pk-data-demonstrating-iv-jwskm6p5fvuc.html #Stockstobuy #stockstowatch #OTLC #STOCK @Charles
0 · Reply
ckruel
ckruel Dec. 3 at 11:46 PM
$OTLC not counting any home run in their pipeline
0 · Reply
ckruel
ckruel Dec. 3 at 11:43 PM
$OTLC $OTLC so at this point that make the co. Worth about $1.69 per share, plus any blue sky on a buyout…anyone?
1 · Reply
Techallure
Techallure Dec. 3 at 8:47 PM
$OTLC $IBIO can only warn so many times … how many times have I mentioned as times such as this ? to be given a small clue, so small we can call it a sub-20 nm clue … and so small but transistor level output can take place Be Prepared
1 · Reply
Ichigodoran
Ichigodoran Dec. 3 at 7:26 PM
$OTLC Oncotelic and Sapu Nano Unveils Broad-Applicability Deciparticle™ Nanomedicine Platform Capable of Formulating Multiple Hydrophobic Peptide, Macrolide, and Polyketide Drugs https://www.barchart.com/story/news/36347580/oncotelic-and-sapu-nano-unveils-broad-applicability-deciparticle-nanomedicine-platform-capable-of-formulating-multiple-hydrophobic-peptide-macrolide-and-polyketide-drugs
0 · Reply
NetworkNewsWire
NetworkNewsWire Dec. 3 at 5:31 PM
BioMedNewsBreaks — $OTLC 45% JV Reports IV Sapu003 Cuts GI Exposure to Everolimus by Up to 67-Fold https://ibn.fm/dVPuX
0 · Reply
Ichigodoran
Ichigodoran Dec. 3 at 12:36 PM
$OTLC News : Oncotelic and Sapu Nano Unveils Broad-Appointment of Broad-Appointment of Sapu Nano Nanomedicine Platform Capable of Formulating Multiple Hydrophobic Peptide, Macrolide, and Polyketide Drugs https://www.marketscreener.com/news/oncotelic-and-sapu-nano-unveils-broad-appointment-of-broad-appointment-of-sapu-nano-nanomedicine-pla-ce7d51d9df81f025
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 2 at 5:45 PM
$OTLC Oncotelic and Sapu Nano Unveils Broad-Applicability Deciparticle™ Nanomedicine Platform Capable of Formulating Multiple Hydrophobic Peptide, Macrolide, and Polyketide Drugs https://www.reddit.com/user/Typical-Stay4553/comments/1pcef48/otlc_oncotelic_and_sapu_nano_unveils/
0 · Reply
NetworkNewsWire
NetworkNewsWire Dec. 2 at 4:35 PM
NetworkNewsBreaks – $OTLC JV Sapu Nano Presents Data Showing Deciparticle Platform Supports Broad Hydrophobic Drug Formulation https://ibn.fm/AYKYf
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 2 at 2:37 PM
Oncotelic Therapeutics Inc ( $OTLC ): $OTLC Oncotelic and Sapu Nano Unveils Br... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177014098 via @Investors_Hub
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 2 at 1:44 PM
#Breaking $OTLC Oncotelic and Sapu Nano Unveils Broad-Applicability Deciparticle™ Nanomedicine Platform Capable of Formulating Multiple Hydrophobic Peptide, Macrolide, and Polyketide Drugs https://finance.yahoo.com/news/oncotelic-sapu-nano-unveils-broad-130000889.html #Stockstobuy #stockstowatch #OTLC #STOCK
0 · Reply
Ichigodoran
Ichigodoran Dec. 1 at 5:50 PM
$OTLC https://stockscan.io/stocks/OTLC
0 · Reply
Ichigodoran
Ichigodoran Dec. 1 at 5:49 PM
$OTLC Oncotelic Achieves Breakthrough $1.7 Billion Pipeline Valuation Through GMP Bio Joint Venture Independent valuation reflects majoradvancement ofOT-101 and Deciparticle™ nanomedicine platform https://www.oncotelic.com/press-releases/?
0 · Reply
JohnHarden
JohnHarden Dec. 1 at 4:14 PM
Oncotelic Therapeutics Inc. (OTCQB: $OTLC) Anticipates Major Fair-Value Uptick Following New Independent JV Valuation https://www.stocktitan.net/news/OTLC/oncotelic-therapeutics-inc-otcqb-otlc-anticipates-major-fair-value-k8xc39s1i9d5.html
0 · Reply
Ichigodoran
Ichigodoran Dec. 1 at 3:07 PM
$OTLC From Chemo Medication (Abraxane) to What's Next? Dr. Vuong has billion-dollar Biotech Value visions! https://www.youtube.com/watch?v=-wcvp8FZrBY
0 · Reply
Ichigodoran
Ichigodoran Dec. 1 at 11:31 AM
$OTLC @Barchart
0 · Reply